OrphaCare, a global specialist for the development and marketing of medical devices for drug delivery and part of the AOP ...
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP ...
HEIDELBERG, Germany & VIENNA, May 27, 2025--(BUSINESS WIRE)--RHEACELL, a German biotech company specialized in the development of stem cell therapies, and AOP Health, a Europe-based leader in ...
The first patient in the United States has been treated with Rapiblyk® (landiolol) at The Valley Hospital, Paramus, NJ.
RAPIBLYK (R) is an ultra-short-acting, selective beta-1 adrenergic receptor blocker administered intravenously in a monitored hospital setting. Its pharmacological profile allows for rapid onset and ...
The Association of Online Publishers (AOP) has announced the shortlist for the 2026 Digital Publishing Awards. Now in its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results